Demant Total Non-Operating Income/Expense 2012-2024 | WILYY
Demant annual/quarterly total non-operating income/expense history and growth rate from 2012 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- Demant total non-operating income/expense for the quarter ending June 30, 2024 was $M, a NAN% increase year-over-year.
- Demant total non-operating income/expense for the twelve months ending June 30, 2024 was $0M, a NAN% increase year-over-year.
- Demant annual total non-operating income/expense for 2023 was $-0.109B, a 176.13% increase from 2022.
- Demant annual total non-operating income/expense for 2022 was $-0.04B, a 23.37% increase from 2021.
- Demant annual total non-operating income/expense for 2021 was $-0.032B, a 8.13% increase from 2020.
| Demant Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2023 | $-109 |
| 2022 | $-40 |
| 2021 | $-32 |
| 2020 | $-30 |
| 2019 | $-36 |
| 2018 | $-26 |
| 2017 | $-17 |
| 2016 | $-15 |
| 2015 | $-10 |
| 2014 | $ |
| 2013 | $-13 |
| 2012 | $-21 |
| 2011 | $-18 |
| Demant Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2024-06-30 | |
| 2023-12-31 | |
| 2023-06-30 | |
| 2022-12-31 | |
| 2022-06-30 | |
| 2021-12-31 | |
| 2021-06-30 | |
| 2020-12-31 | |
| 2020-06-30 | |
| 2019-12-31 | |
| 2019-06-30 | |
| 2018-12-31 | |
| 2018-06-30 | |
| 2017-12-31 | |
| 2017-06-30 | |
| 2016-12-31 | |
| 2016-06-30 | |
| 2015-12-31 | |
| 2014-06-30 | |
| 2013-12-31 | |
| 2013-06-30 | |
| 2012-12-31 | |
| 2012-06-30 | |
| 2011-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $7.946B | $3.252B |
| Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company's business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
| Boston Scientific (BSX) | United States | $154.781B | 41.84 |
| Stryker (SYK) | United States | $150.988B | 32.49 |
| EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
| Medtronic (MDT) | Ireland | $116.457B | 17.30 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| Agilent Technologies (A) | United States | $42.120B | 27.91 |
| GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
| ResMed (RMD) | United States | $34.834B | 26.83 |
| Terumo (TRUMY) | Japan | $27.701B | 39.39 |
| Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.443B | 12.84 |
| Insulet (PODD) | United States | $20.179B | 80.36 |
| Baxter (BAX) | United States | $15.731B | 10.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
| Bio-Rad Laboratories (BIO) | United States | $9.670B | 32.87 |
| Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
| Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
| ICU Medical (ICUI) | United States | $3.878B | 36.92 |
| Envista Holdings (NVST) | United States | $3.750B | 29.85 |
| Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
| Haemonetics (HAE) | United States | $3.164B | 14.89 |
| GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.832B | 18.23 |
| Neogen (NEOG) | United States | $2.315B | 26.67 |
| LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
| AtriCure (ATRC) | United States | $1.997B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
| InMode (INMD) | Israel | $1.269B | 10.61 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
| Evolus (EOLS) | United States | $0.849B | 0.00 |
| CeriBell (CBLL) | United States | $0.810B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.21 |
| Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
| Valneva SE (VALN) | France | $0.563B | 0.00 |
| Omeros (OMER) | United States | $0.526B | 0.00 |
| SNDL (SNDL) | Canada | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.26 |
| Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Quanterix (QTRX) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Biote (BTMD) | United States | $0.261B | 5.73 |
| Zynex (ZYXI) | United States | $0.252B | 52.80 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
| Brainsway (BWAY) | Israel | $0.200B | 106.40 |
| MacroGenics (MGNX) | United States | $0.174B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 11.44 |
| Exagen (XGN) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| INLIF (INLF) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.051B | 14.60 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |